What can we learn from clinical trials of anticonvulsant drugs in epilepsy?

This publication has 46 references indexed in Scilit:

• Harnessing the Clinical Potential of Antiepileptic Drug Therapy
  CNS Drugs, 2001
• Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind study
  The Lancet, 1999
• Transaminase elevation on placebo during Phase I trials: prevalence and significance
  British Journal of Clinical Pharmacology, 1999
• Polypharmacy with Anticonvulsants
  CNS Drugs, 1997
• Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy
  The Lancet, 1996
• Lamotrigine
  Drugs, 1995
• A MULTICENTRE COMPARATIVE TRIAL OF SODIUM VALPROATE AND CARBAMAZEPINE IN PAEDIATRIC EPILEPSY
  Developmental Medicine and Child Neurology, 1995
• Lamotrigine as an Add-On Drug in the Management of Lennox-Gastaut Syndrome
  European Neurology, 1992
• Hazards of Inference: The Active Control Investigation
  Epilepsia, 1989
• Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic Seizures
  New England Journal of Medicine, 1985